Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Consolidated Statements of Operations and Comprehensive Loss
Collaboration revenue	$ 6,941	$ 9,041
Operating expenses:
In-process research and development	10,000	152,344
Research and development	177,286	129,542
General and administrative	43,768	32,955
Total operating expenses	231,054	314,841
Loss from operations	(224,113)	(305,800)
Interest income	11,719	12,837
Net loss	$ (212,394)	$ (292,963)
Per share information:
Net loss per share, basic	$ (2.43)	$ (5)
Net loss per share, diluted	$ (2.43)	$ (5)
Weighted-average shares outstanding, basic	87,350,956	58,639,441
Weighted-average shares outstanding, diluted	87,350,956	58,639,441
Comprehensive loss:
Net loss	$ (212,394)	$ (292,963)
Unrealized (loss) gain on marketable securities	(57)	35
Comprehensive loss	$ (212,451)	$ (292,928)